Crossmark

High performance plasma amyloid-β biomarkers for Alzheimer’s disease

Crossref DOI link: https://doi.org/10.1038/nature25456

Published Online: 2018-01-31

Published Print: 2018-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nakamura, Akinori

Kaneko, Naoki

Villemagne, Victor L.

Kato, Takashi

Doecke, James

Doré, Vincent

Fowler, Chris

Li, Qiao-Xin

Martins, Ralph

Rowe, Christopher

Tomita, Taisuke

Matsuzaki, Katsumi

Ishii, Kenji

Ishii, Kazunari

Arahata, Yutaka

Iwamoto, Shinichi

Ito, Kengo

Tanaka, Koichi

Masters, Colin L.

Yanagisawa, Katsuhiko
License Information

Text and Data Mining valid from 2018-01-31
More Information

Article History

Received: 22 March 2017

Accepted: 11 December 2017

First Online: 31 January 2018

Competing interests

: N.K., S.I. and K.T. are employees of Shimadzu. NCGG and Shimadzu have patents pending that are related to this study: PCT/JP2016/076706 and PCT/JP2015/064386. Shimadzu has patents pending: JP 2015-140899 and US 15/209331. V.L.V. received grants from CSIRO and NHMRC during the study. J.D. received grants from CRC for Mental Health, during the study, and has patent TW8546/AU pending.